Providing the Starting Material to the Manufacturer of an Approved and Commercially Available Autologous CAR-T Cell Treatment
Crossref DOI link: https://doi.org/10.1007/978-3-030-94353-0_6
Published Online: 2022-02-07
Published Print: 2022
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bonig, Halvard
Chabannon, Christian http://orcid.org/0000-0002-3755-4889
Lozano, Miquel
Funding for this research was provided by:
European Society for Blood and Marrow Transplantation
The European Hematology Association
Text and Data Mining valid from 2022-01-01
Version of Record valid from 2022-02-07
Chapter History
First Online: 7 February 2022